Universitätsklinikum Eppendorf
Welcome,         Profile    Billing    Logout  
 27 Trials 
18 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fiedler, Walter
NCT03897127: Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagnosed AML and Intermediate- or Adverse Genetics

Recruiting
3
882
Europe
Cytarabine, Daunorubicin, CPX-351
University of Ulm, Jazz Pharmaceuticals
Acute Myeloid Leukemia
06/27
06/27
NCT06648889: Isatuximab in Adult Patients with Cytologic or Molecular Relapsed/refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

Recruiting
2
40
Europe
Isatuximab, Bortezomib
Goethe University, Sanofi
T-ALL
02/28
08/28
AUGMENT-101, NCT04065399 / 2020-004104-34: A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Jan 2024 - Dec 2024: Market entry for acute leukemias
Hourglass Feb 2024 - Mar 2024 : Q1'24 - PDUFA date from FDA for R/R KMT2Ar acute leukemia
Dec 2022 - Dec 2023: Submission in US for relapsed/refractory acute leukemia
Jul 2023 - Sep 2023: Data from AUGMENT-101 trial for r/r AML
Checkmark Updated data from P1 portion of P1/2 AUGMENT-101 trial for AML
More
Recruiting
1/2
413
Europe, Canada, US, RoW
revumenib, SNDX-5613, cobicistat
Syndax Pharmaceuticals, Syndax Pharmaceuticals, Inc
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia of Ambiguous Lineage
12/27
12/27
DODEKA, NCT04471987: Safety and Early Signs of Efficacy of IL12-L19L19.

Recruiting
1
94
Europe
IL12-L19L19, Dodekin
Philogen S.p.A.
Advanced Solid Tumor, Metastatic Solid Tumor
12/25
12/25
NCT04230265: Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies

Recruiting
1
90
Europe
Cyclophosphamide (Non-IMP), Fludarabine (Non-IMP), TM123 (IMP), UniCAR02-T (IMP)
AvenCell Europe GmbH, PHARMALOG Institut für klinische Forschung GmbH
Acute Myeloid Leukemia (AML)
05/25
09/25
Rösch, Thomas
Endocuff, NCT03442738: A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®)

Completed
N/A
1382
Europe
Endocuff group
Universitätsklinikum Hamburg-Eppendorf, Norgine
Adenoma Detection Rate
09/21
09/22
CRYLEO, NCT06249841: Feasibility of Cryobiopsy from the Bile Duct -

Completed
N/A
15
Europe
1.1mm flexible Cryoprobe SU, Comparator: SpyBite Max Forceps
Erbe Elektromedizin GmbH
Neoplasms, Bile Duct
08/24
12/24
STREET, NCT04913077: Submucosal Tumor Removal by Endoscopic Excision Therapy

Suspended
N/A
200
Europe
removal of submucosal gastric tumor preferably by Full Thickness Resection Device (FTRD), Endoscopic submucosal dissection (ESD)
Universitätsklinikum Hamburg-Eppendorf, Ovesco Endoscopy AG
Submucosal Tumor of Stomach
11/24
02/25
Augustin, Matthias
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Recruiting
3
595
Europe, Canada, Japan, US, RoW
Baricitinib, LY3009104, Placebo
Eli Lilly and Company
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical
09/24
08/29
NCT06046729: A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting
2
350
Europe, Canada, US, RoW
Eltrekibart, LY3041658, Placebo
Eli Lilly and Company
Hidradenitis Suppurativa
08/25
07/26
NCT04971161 / 2020-004960-24: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)

Active, not recruiting
2
152
Europe
allo-APZ2-CVU, Skin-derived ABCB5-positive dermal mesenchymal stromal cells, Placebo
RHEACELL GmbH & Co. KG, FGK Clinical Research GmbH
Skin Ulcer Venous Stasis Chronic
06/26
06/26
PsoBarrier, NCT02668341: Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries

Enrolling by invitation
N/A
1304
Europe
non-interventional, non-interventional survey study
Universitätsklinikum Hamburg-Eppendorf, Sandoz
Psoriasis
09/20
12/20
POWER, NCT05855499: Plasma on Chronic Wounds for Epidermal Regeneration

Recruiting
N/A
167
NA
CPtcube, CPTpatch
Coldplasmatech, German Federal Ministry of Education and Research
Chronic Ulcer of Lower Extremity
12/25
12/25
NCT01848028: PsoBest - the German Psoriasis Registry

Recruiting
N/A
3500
Europe
Universitätsklinikum Hamburg-Eppendorf, Berufsverband der Deutschen Dermatologen e.V. (www.bvdd.de), Deutsche Dermatologische Gesellschaft e.V. (https://derma.de), AbbVie, Biogen, Janssen-Cilag G.m.b.H, medac GmbH, Merck Sharp & Dohme LLC, Novartis Pharmaceuticals, Pfizer Pharmaceuticals Ltd., Merck Serono GmbH, Germany, PsoNet.eu (http://www.psonet.eu/), Celgene, Eli Lilly and Company, Amgen, Almirall Hermal GmbH, UCB Pharma, Bristol-Myers Squibb, Viatris Inc., LEO Pharma
Psoriasis, Psoriatic-arthritis
12/32
12/32
Renteln, Daniel von
RITUAL, NCT05732233: Ultivision AI CADe Randomized Controlled Trial

Terminated
N/A
137
Europe, Canada, US
Ultivision AI
Satisfai Health, Inc., Meditrial USA Inc.
Colon Adenoma, Polyp of Colon, Adenoma Colon
02/24
02/24
NCT05653843: MANTIS Endoscopic Clipping Study

Completed
N/A
290
Canada, Japan, US, RoW
Endoscopic clip placement in the gastrointestinal tract.
Boston Scientific Corporation
Hemostasis, Perforation Colon, Feeding Tube Complication, Endoscopy
08/24
08/24
h-APC EMR, NCT04015765: Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence

Recruiting
N/A
300
Canada
Hybrid Argon Plasma Coagulation and EMR procedure
Centre hospitalier de l'Université de Montréal (CHUM), Penn State University, University of Milan, Erbe Elektromedizin GmbH, Unity Health Toronto, University of British Columbia
Colorectal Cancer, Polyp of Colon
06/25
12/25
Gebhardt, Christoffer
NCT05529316: A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma

Active, not recruiting
2
220
Europe, US, RoW
Botensilimab, AGEN1181, Balstilimab, AGEN2034
Agenus Inc.
Advanced Melanoma
05/28
05/28
Lehmberg, Kai
No trials found

Download Options